Basic Research on Listeria Bacteria Leads to Unique Cancer Therapy

Basic research on Listeria bacteria leads to unique cancer therapy

After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system to cause listeriosis, Daniel Portnoy and his colleagues have discovered a way to turn the bacteria into a potent booster of the immune system—and a potential weapon against cancer.

Breakthrough Study on Listeria Bacteria Paves Way for Innovative Cancer

In a groundbreaking advancement poised to revolutionize immunotherapy, researchers at the University of California, Berkeley, led by molecular biologist Daniel Portnoy, have transformed the pathogenic bacterium Listeria monocytogenes into a formidable immune system stimulant with promising applications in cancer treatment. This innovative approach harnesses decades of foundational research into Listeria’s intricate interactions with mammalian ho…